Citation: | Dandan Yu, Yanghaopeng Long, Ling Xu, Jian-Bao Han, Jiawei Xi, Jianlin Xu, Lu-Xiu Yang, Xiao-Li Feng, Qing-Cui Zou, Wang Qu, Jiangwei Lin, Ming-Hua Li, Yong-Gang Yao. Infectivity of SARS-CoV-2 and protection against reinfection in rats. Zoological Research, 2022, 43(6): 945-948. doi: 10.24272/j.issn.2095-8137.2022.339 |
[1] |
Cao L, Li YJ, Yang SD, Li GG, Zhou QF, Sun J, et al. 2022. The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants. Science Translational Medicine, 14(661): eabm7621. doi: 10.1126/scitranslmed.abm7621
|
[2] |
Cohen J. 2020. From mice to monkeys, animals studied for coronavirus answers. Science, 368(6488): 221−222. doi: 10.1126/science.368.6488.221
|
[3] |
Colombo VC, Sluydts V, Mariën J, Vanden Broecke B, Van Houtte N, Leirs W, et al. 2022. SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, Belgium. Transboundary and Emerging Diseases, 69(5): 3016−3021. doi: 10.1111/tbed.14219
|
[4] |
Dagotto G, Mercado NB, Martinez DR, Hou YJ, Nkolola JP, Carnahan RH, et al. 2021. Comparison of subgenomic and total RNA in SARS-CoV-2-challenged rhesus macaques. Journal of Virology, 95(8): e02370−20.
|
[5] |
Fan CF, Wu Y, Rui X, Yang YS, Ling C, Liu SS, et al. 2022. Animal models for COVID-19: advances, gaps and perspectives. Signal Transduction and Targeted Therapy, 7(1): 220. doi: 10.1038/s41392-022-01087-8
|
[6] |
Feng XL, Yu D, Zhang M, Li X, Zou QC, Ma W, et al. 2022. Characteristics of replication and pathogenicity of SARS-CoV-2 Alpha and Delta isolates. Virologica Sinica,https://doi.org/10.1016/j.virs.2022.09.007
|
[7] |
Huang HY, Zhu YC, Niu ZB, Zhou LL, Sun Q. 2021. SARS-CoV-2 N501Y variants of concern and their potential transmission by mouse. Cell Death & Differentiation, 28(10): 2840−2842.
|
[8] |
Khoury EE, Knaney Y, Fokra A, Kinaneh S, Azzam Z, Heyman SN, et al. 2021. Pulmonary, cardiac and renal distribution of ACE2, furin, TMPRSS2 and ADAM17 in rats with heart failure: potential implication for COVID-19 disease. Journal of Cellular and Molecular Medicine, 25(8): 3840−3855. doi: 10.1111/jcmm.16310
|
[9] |
Modlinska K, Pisula W. 2020. The Norway rat, from an obnoxious pest to a laboratory pet. eLife, 9: e50651. doi: 10.7554/eLife.50651
|
[10] |
Muñoz-Fontela C, Dowling WE, Funnell SGP, Gsell PS, Riveros-Balta AX, Albrecht RA, et al. 2020. Animal models for COVID-19. Nature, 586(7830): 509−515. doi: 10.1038/s41586-020-2787-6
|
[11] |
Savoia C, Volpe M, Kreutz R. 2021. Hypertension, a moving target in COVID-19: current views and perspectives. Circulation Research, 128(7): 1062−1079. doi: 10.1161/CIRCRESAHA.121.318054
|
[12] |
Shuai HP, Chan JFW, Yuen TTT, Yoon C, Hu JC, Wen L, et al. 2021. Emerging SARS-CoV-2 variants expand species tropism to murines. eBioMedicine, 73: 103643. doi: 10.1016/j.ebiom.2021.103643
|
[13] |
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. 2020. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA, 324(8): 782−793. doi: 10.1001/jama.2020.12839
|
[14] |
Zhang C, Cui H, Li ET, Guo ZD, Wang TC, Yan F, et al. 2022. The SARS-CoV-2 B. 1.351 variant can transmit in rats but not in mice. Frontiers in Immunology, 13: 869809. doi: 10.3389/fimmu.2022.869809
|
![]() |
![]() |